Invesco Exchange-Traded Fund Trust. Holdings as of Jul 31, 2026, from Form N-PORT.
Share of net assets at the report date, for the whole fund across all share classes.
| Holding | Weight | Value | Shares or units |
|---|---|---|---|
| Invesco Private Prime FundCash or money market | 7.93% | $37.43M | 37,423,681 |
| Abbott LaboratoriesABT | 5.67% | $26.78M | 253,317 |
| AbbVie Inc.ABBV | 5.48% | $25.86M | 103,038 |
| Amgen Inc.AMGN | 5.33% | $25.17M | 65,359 |
| Johnson & JohnsonJNJ | 5.18% | $24.45M | 95,373 |
| Merck & Co., Inc.MRK | 5.06% | $23.87M | 183,363 |
| Eli Lilly and Co.LLY | 5.02% | $23.69M | 20,622 |
| Corcept Therapeutics Inc.CORT | 4.96% | $23.43M | 204,618 |
| Gilead Sciences, Inc.GILD | 4.53% | $21.38M | 164,182 |
| Pfizer Inc.PFE | 4.50% | $21.24M | 849,353 |
| Amneal Pharmaceuticals, Inc.AMRX | 3.75% | $17.69M | 965,545 |
| Invesco Private Government FundCash or money market | 3.73% | $17.63M | 17,629,582 |
| Liquidia Corp.LQDA | 3.66% | $17.28M | 205,492 |
| Travere Therapeutics, Inc.TVTX | 3.30% | $15.59M | 278,876 |
| Ligand Pharmaceuticals Inc.LGND | 3.20% | $15.09M | 52,490 |
| Regeneron Pharmaceuticals, Inc.REGN | 3.14% | $14.84M | 19,460 |
| Harmony Biosciences Holdings, Inc.HRMY | 3.06% | $14.46M | 410,448 |
| Bristol-Myers Squibb Co.BMY | 2.94% | $13.90M | 212,823 |
| Viatris Inc.VTRS | 2.83% | $13.34M | 759,533 |
| Jazz Pharmaceuticals PLCJAZZ | 2.79% | $13.16M | 52,047 |
| Biogen Inc.BIIB | 2.75% | $12.97M | 63,929 |
| Collegium Pharmaceutical, Inc.COLL | 2.74% | $12.94M | 365,632 |
| Prestige Consumer Healthcare Inc.PBH | 2.74% | $12.92M | 257,185 |
| Ocular Therapeutix, Inc.OCUL | 2.58% | $12.17M | 1,489,689 |
| ANI Pharmaceuticals, Inc.ANIP | 2.55% | $12.02M | 151,712 |
| Tarsus Pharmaceuticals, Inc.TARS | 2.53% | $11.92M | 201,930 |
| Perrigo Co. PLCPRGO | 2.45% | $11.56M | 1,143,527 |
| Supernus Pharmaceuticals, Inc.SUPN | 2.44% | $11.54M | 258,498 |
| Innoviva, Inc.INVA | 2.42% | $11.42M | 544,496 |
| United Therapeutics Corp.UTHR | 2.34% | $11.06M | 21,361 |
| Invesco Government & Agency PortfolioCash or money market | 0.10% | $474.56K | 474,555 |
| OmniAb, Inc.OABI | 0.00% | $0 | 39,023 |
| OmniAb, Inc.OABI | 0.00% | $0 | 39,023 |
Holdings from the fund's latest Form N-PORT; expense ratio (net of fee waivers) from the risk/return summary of its prospectus; fund type from Form N-CEN. Prices are end-of-day closes adjusted for splits; total return also reinvests distributions.